Illumina Director Sells $465,100 in Stock (ILMN)
Illumina (NASDAQ:ILMN) Director David Walt sold 5,000 shares of the company’s stock in a transaction dated Wednesday, October 30th. The stock was sold at an average price of $93.02, for a total transaction of $465,100.00. Following the transaction, the director now directly owns 911,488 shares in the company, valued at approximately $84,786,614. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link.
Illumina (NASDAQ:ILMN) traded up 2.36% on Friday, hitting $95.714. 1,591,981 shares of the company’s stock traded hands. Illumina has a 52 week low of $47.02 and a 52 week high of $84.85. The stock’s 50-day moving average is $83.70 and its 200-day moving average is $75.39. The company has a market cap of $12.009 billion and a price-to-earnings ratio of 111.59.
Illumina (NASDAQ:ILMN) last announced its earnings results on Monday, October 21st. The company reported $0.45 earnings per share for the quarter, beating the analysts’ consensus estimate of $0.40 by $0.05. The company had revenue of $357.00 million for the quarter, compared to the consensus estimate of $343.42 million. During the same quarter in the prior year, the company posted $0.41 earnings per share. The company’s quarterly revenue was up 24.9% on a year-over-year basis. On average, analysts predict that Illumina will post $1.78 earnings per share for the current fiscal year.
A number of analysts have recently weighed in on ILMN shares. Analysts at Wedbush raised their price target on shares of Illumina from $65.00 to $72.00 in a research note to investors on Wednesday, October 23rd. They now have a “neutral” rating on the stock. Separately, analysts at Janney Montgomery Scott raised their price target on shares of Illumina from $86.00 to $89.00 in a research note to investors on Wednesday, October 23rd. They now have a “neutral” rating on the stock. Finally, analysts at Cantor Fitzgerald raised their price target on shares of Illumina from $63.00 to $72.00 in a research note to investors on Wednesday, October 23rd. They now have a “hold” rating on the stock. Eight equities research analysts have rated the stock with a hold rating and eight have assigned a buy rating to the company’s stock. The stock has a consensus rating of “Buy” and an average target price of $80.79.
Illumina, Inc (NASDAQ:ILMN) is a developer and manufacturer of life science tools and integrated systems for the analysis of genetic variation and function.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.